Maria Dobek, the Vice President of $JANX, sold 2,038 shares of the company on 05-11-2026 for an estimated $28,878. We received data on the trade from a recent SEC filing. This was a sale of approximately 5.9% of their shares of this class of stock. Following this trade, they now own 32,270 shares of this class of $JANX stock.
$JANX Insider Trading Activity
$JANX insiders have traded $JANX stock on the open market 10 times in the past 6 months. Of those trades, 0 have been purchases and 10 have been sales.
Here’s a breakdown of recent trading of $JANX stock by insiders over the last 6 months:
- ANDREW HOLLMAN MEYER (Chief Business Officer) has made 0 purchases and 4 sales selling 8,545 shares for an estimated $235,717.
- DAVID ALAN CAMPBELL (President and CEO) sold 8,072 shares for an estimated $110,828
- MARIA DOBEK (Vice President, Accounting) has made 0 purchases and 2 sales selling 3,500 shares for an estimated $48,951.
- ZACHARIAH MCIVER (Chief Medical Officer) sold 2,714 shares for an estimated $37,263
- THOMAS DIRAIMONDO (Chief Scientific Officer) sold 2,505 shares for an estimated $34,393
- CHARLES M. WINTER (Chief Technical Officer) sold 2,401 shares for an estimated $32,965
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$JANX Hedge Fund Activity
We have seen 123 institutional investors add shares of $JANX stock to their portfolio, and 78 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC removed 5,543,678 shares (-61.2%) from their portfolio in Q4 2025, for an estimated $76,502,756
- PARADIGM BIOCAPITAL ADVISORS LP removed 2,920,258 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $40,299,560
- STATE STREET CORP added 1,962,486 shares (+103.8%) to their portfolio in Q4 2025, for an estimated $27,082,306
- TCG CROSSOVER MANAGEMENT, LLC added 1,789,617 shares (+inf%) to their portfolio in Q4 2025, for an estimated $24,696,714
- PROSIGHT MANAGEMENT, LP added 1,527,173 shares (+176.5%) to their portfolio in Q4 2025, for an estimated $21,074,987
- BLACKROCK, INC. added 1,353,033 shares (+33.2%) to their portfolio in Q1 2026, for an estimated $18,807,158
- T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 970,965 shares (-99.8%) from their portfolio in Q4 2025, for an estimated $13,399,317
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$JANX Analyst Ratings
Wall Street analysts have issued reports on $JANX in the last several months. We have seen 1 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- HC Wainwright & Co. issued a "Buy" rating on 11/25/2025
To track analyst ratings and price targets for $JANX, check out Quiver Quantitative's $JANX forecast page.
$JANX Price Targets
Multiple analysts have issued price targets for $JANX recently. We have seen 11 analysts offer price targets for $JANX in the last 6 months, with a median target of $36.0.
Here are some recent targets:
- Robert Driscoll from Wedbush set a target price of $36.0 on 05/08/2026
- Brad Canino from Guggenheim set a target price of $58.0 on 05/08/2026
- Kelsey Goodwin from Piper Sandler set a target price of $26.0 on 05/08/2026
- Boris Peaker from Jones Trading set a target price of $28.0 on 04/28/2026
- Etzer Darout from Barclays set a target price of $14.0 on 04/20/2026
- David Dai from UBS set a target price of $15.0 on 04/15/2026
- Josh Schimmer from Cantor Fitzgerald set a target price of $100.0 on 02/27/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
